Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NEUROONE MEDICAL TECHNOLOGIES CorpNMTC · Entity 7808 | Market Development Director | August 28, 2026 | August 28, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NEUROONE MEDICAL TECHNOLOGIES Corp
Report date August 28, 2026 · Filed August 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $1.77 · Expires 2036-08-27 | Direct | 12,500 |
Reported balance
After 2026-08-28 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-08-28 · Grant · Acquired 12,500 · Balance 12,500 F1: 25% will vest on August 28, 2027, and the remaining 75% will vest in 12 equal quarterly installments. |
Filing footnotes · ownership attribution and instrument terms
F1: 25% will vest on August 28, 2027, and the remaining 75% will vest in 12 equal quarterly installments.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 28, 2026 Filed Aug 28, 2026 17:00 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | GrantOption to Purchase Common Stock · Derivative | 12,500 | $0.00 Strike: $1.77 | $0.00 |
DisclosureSEC source: 0001709738-26-000011 · primary_doc.xml · derivative · entry 1 Christianson Mark · CIK 0001709738 · Market Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2036-08-27 F1 · derivative.exercise_date: 25% will vest on August 28, 2027, and the remaining 75% will vest in 12 equal quarterly installments. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:39 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | SaleCommon Stock | 10,000 | $3.18 | $31,773.00 |
DisclosureSEC source: 0001709738-26-000010 · primary_doc.xml · nonDerivative · entry 1 Christianson Mark · CIK 0001709738 · Market Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,692 Read SEC document |
| March 31, 2026 Filed Apr 1, 2026 20:11 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 253 | $0.78 | $196.58 |
DisclosureSEC source: 0001709738-26-000009 · primary_doc.xml · nonDerivative · entry 2 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 198,667 Read SEC document |
| March 30, 2026 Filed Apr 1, 2026 20:11 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | SaleCommon Stock | 15,363 | $0.74 | $11,368.62 |
DisclosureSEC source: 0001709738-26-000009 · primary_doc.xml · nonDerivative · entry 1 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 198,920 Read SEC document |
| March 13, 2026 Filed Mar 16, 2026 19:30 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | SaleCommon Stock | 100 | $0.80 | $80.00 |
DisclosureSEC source: 0001709738-26-000008 · primary_doc.xml · nonDerivative · entry 2 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 214,283 Read SEC document |
| March 12, 2026 Filed Mar 16, 2026 19:30 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | SaleCommon Stock | 817 | $0.80 | $653.60 |
DisclosureSEC source: 0001709738-26-000008 · primary_doc.xml · nonDerivative · entry 1 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 214,383 Read SEC document |
| March 11, 2026 Filed Mar 12, 2026 19:58 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | SaleCommon Stock | 2,109 | $0.80 | $1,687.20 |
DisclosureSEC source: 0001709738-26-000007 · primary_doc.xml · nonDerivative · entry 2 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 215,200 F2 · price: The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $0.80 and 0.805 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 19:58 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | SaleCommon Stock | 11,611 | $0.80 | $9,288.80 |
DisclosureSEC source: 0001709738-26-000007 · primary_doc.xml · nonDerivative · entry 1 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 217,309 F1 · price: The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $0.80 and 0.8102 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 19:20 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 1,812 | $0.68 | $1,232.16 |
DisclosureSEC source: 0001709738-26-000006 · primary_doc.xml · nonDerivative · entry 1 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 228,920 Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 21:11 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 253 | $0.76 | $191.77 |
DisclosureSEC source: 0001709738-26-000001 · primary_doc.xml · nonDerivative · entry 1 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 230,732 Read SEC document |
| September 30, 2025 Filed Oct 1, 2025 18:15 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 253 | $0.89 | $224.82 |
DisclosureSEC source: 0001709738-25-000011 · primary_doc.xml · nonDerivative · entry 1 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 230,985 Read SEC document |
| September 05, 2025 Filed Sep 9, 2025 20:15 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | SaleCommon Stock | 30,000 | $0.74 | $22,203.00 |
DisclosureSEC source: 0001709738-25-000010 · primary_doc.xml · nonDerivative · entry 1 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 231,238 F1 · price: The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $0.7400 to $0.7518 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 16:22 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 253 | $0.68 | $171.53 |
DisclosureSEC source: 0001709738-25-000008 · primary_doc.xml · nonDerivative · entry 1 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 261,238 Read SEC document |
| June 04, 2025 Filed Jun 5, 2025 20:08 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | SaleCommon Stock | 10,000 | $0.58 | $5,804.00 |
DisclosureSEC source: 0001709738-25-000007 · primary_doc.xml · nonDerivative · entry 1 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 261,491 Read SEC document |
| May 22, 2025 Filed May 23, 2025 20:03 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | SaleCommon Stock | 8,967 | $0.62 | $5,586.44 |
DisclosureSEC source: 0001709738-25-000006 · primary_doc.xml · nonDerivative · entry 2 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 271,491 Read SEC document |
| May 21, 2025 Filed May 23, 2025 20:03 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | SaleCommon Stock | 14 | $0.65 | $9.10 |
DisclosureSEC source: 0001709738-25-000006 · primary_doc.xml · nonDerivative · entry 1 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 280,458 Read SEC document |
| May 20, 2025 Filed May 21, 2025 20:14 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | SaleCommon Stock | 3,013 | $0.66 | $1,975.93 |
DisclosureSEC source: 0001709738-25-000005 · primary_doc.xml · nonDerivative · entry 2 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 280,472 Read SEC document |
| May 19, 2025 Filed May 21, 2025 20:14 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | SaleCommon Stock | 8,006 | $0.67 | $5,329.59 |
DisclosureSEC source: 0001709738-25-000005 · primary_doc.xml · nonDerivative · entry 1 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 283,485 Read SEC document |
| April 17, 2025 Filed Apr 21, 2025 21:11 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | GrantOption to Purchase Common Stock · Derivative | 200,000 | $0.00 Strike: $0.58 | $0.00 |
DisclosureSEC source: 0001709738-25-000004 · primary_doc.xml · derivative · entry 1 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2035-04-16 F1 · derivative.exercise_date: 25% will vest on April 17, 2026, and the remaining 75% will vest in 12 equal quarterly installments. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 20:04 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 253 | $0.85 | $215.10 |
DisclosureSEC source: 0001709738-25-000003 · primary_doc.xml · nonDerivative · entry 1 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 291,491 Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 21:13 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 1,812 | $1.16 | $2,101.92 |
DisclosureSEC source: 0001709738-25-000002 · primary_doc.xml · nonDerivative · entry 1 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 291,744 Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 18:41 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 90 | $1.15 | $103.50 |
DisclosureSEC source: 0001709738-25-000001 · primary_doc.xml · nonDerivative · entry 1 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 293,556 Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 20:40 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 343 | $0.83 | $283.32 |
DisclosureSEC source: 0001213900-25-000717 · ownership.xml · nonDerivative · entry 1 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 293,646 Read SEC document |
| November 30, 2024 Filed Dec 3, 2024 21:57 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 90 | $0.62 | $56.08 |
DisclosureSEC source: 0001709738-24-000015 · primary_doc.xml · nonDerivative · entry 1 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 293,989 Read SEC document |
| October 31, 2024 Filed Nov 1, 2024 21:14 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 90 | $0.97 | $87.30 |
DisclosureSEC source: 0001709738-24-000014 · primary_doc.xml · nonDerivative · entry 1 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 294,079 Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 15:32 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 343 | $0.99 | $339.57 |
DisclosureSEC source: 0001709738-24-000013 · primary_doc.xml · nonDerivative · entry 1 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 294,169 Read SEC document |
| August 31, 2024 Filed Sep 4, 2024 15:36 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 90 | $0.80 | $71.68 |
DisclosureSEC source: 0001709738-24-000012 · primary_doc.xml · nonDerivative · entry 1 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 294,512 Read SEC document |
| July 31, 2024 Filed Aug 2, 2024 18:31 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 90 | $0.75 | $67.50 |
DisclosureSEC source: 0001709738-24-000011 · primary_doc.xml · nonDerivative · entry 1 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 294,602 Read SEC document |
| June 30, 2024 Filed Jul 2, 2024 15:00 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 343 | $0.80 | $274.40 |
DisclosureSEC source: 0001709738-24-000010 · primary_doc.xml · nonDerivative · entry 1 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 294,692 Read SEC document |
| June 06, 2024 Filed Jun 11, 2024 19:34 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | SaleCommon Stock | 2,189 | $0.88 | $1,917.56 |
DisclosureSEC source: 0001709738-24-000009 · primary_doc.xml · nonDerivative · entry 1 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 295,035 Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 13:49 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | SaleCommon Stock | 25,800 | $0.88 | $22,662.72 |
DisclosureSEC source: 0001709738-24-000008 · primary_doc.xml · nonDerivative · entry 1 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 297,224 F1 · price: The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $0.8741 to $0.8801 per share. Upon request by the SEC staff, the issuer or any securityholder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 15:39 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 90 | $0.93 | $83.69 |
DisclosureSEC source: 0001709738-24-000007 · primary_doc.xml · nonDerivative · entry 1 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 323,024 Read SEC document |
| April 30, 2024 Filed May 2, 2024 12:57 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 90 | $1.13 | $101.70 |
DisclosureSEC source: 0001709738-24-000006 · primary_doc.xml · nonDerivative · entry 1 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 323,114 Read SEC document |
| April 21, 2024 Filed Apr 23, 2024 14:09 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 2,030 | $1.15 | $2,334.50 |
DisclosureSEC source: 0001709738-24-000005 · primary_doc.xml · nonDerivative · entry 1 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 323,204 Read SEC document |
| March 31, 2024 Filed Apr 2, 2024 15:45 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 90 | $1.20 | $108.00 |
DisclosureSEC source: 0001709738-24-000004 · primary_doc.xml · nonDerivative · entry 1 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 325,234 Read SEC document |
| February 29, 2024 Filed Mar 4, 2024 18:50 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 90 | $1.21 | $108.90 |
DisclosureSEC source: 0001709738-24-000003 · primary_doc.xml · nonDerivative · entry 1 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 325,324 Read SEC document |
| February 18, 2024 Filed Feb 21, 2024 15:44 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001709738-24-000002 · primary_doc.xml · nonDerivative · entry 1 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 325,414 F1 · shares: Represents a grant of restricted stock units, which vest as to 25% of the shares on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| January 31, 2024 Filed Feb 1, 2024 18:41 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 90 | $1.25 | $112.50 |
DisclosureSEC source: 0001709738-24-000001 · primary_doc.xml · nonDerivative · entry 1 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,414 Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 18:29 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 90 | $1.58 | $142.20 |
DisclosureSEC source: 0001213900-24-000531 · ownership.xml · nonDerivative · entry 1 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,504 Read SEC document |
| December 27, 2023 Filed Dec 27, 2023 23:08 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | SaleCommon Stock | 31,445 | $1.46 | $45,859.39 |
DisclosureSEC source: 0001709738-23-000016 · primary_doc.xml · nonDerivative · entry 2 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,594 Read SEC document |
| December 26, 2023 Filed Dec 27, 2023 23:08 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | SaleCommon Stock | 6,848 | $1.35 | $9,269.45 |
DisclosureSEC source: 0001709738-23-000016 · primary_doc.xml · nonDerivative · entry 1 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 332,039 Read SEC document |
| December 22, 2023 Filed Dec 26, 2023 21:01 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | SaleCommon Stock | 1,800 | $1.40 | $2,520.00 |
DisclosureSEC source: 0001709738-23-000015 · primary_doc.xml · nonDerivative · entry 2 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 338,887 Read SEC document |
| December 21, 2023 Filed Dec 26, 2023 21:01 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | SaleCommon Stock | 9,907 | $1.40 | $13,869.80 |
DisclosureSEC source: 0001709738-23-000015 · primary_doc.xml · nonDerivative · entry 1 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 340,687 Read SEC document |
| November 30, 2023 Filed Dec 4, 2023 21:24 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 90 | $1.45 | $130.50 |
DisclosureSEC source: 0001709738-23-000014 · primary_doc.xml · nonDerivative · entry 1 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 350,594 Read SEC document |
| November 09, 2023 Filed Nov 13, 2023 22:43 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | GrantOption to Purchase Common Stock · Derivative | 17,688 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0001709738-23-000013 · primary_doc.xml · derivative · entry 1 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,688 Underlying: Common Stock · 17,688 shares Expires 2033-11-08 F1 · derivative.exercise_date: 25% will vest on November 9, 2024, and the remaining 75% will vest in 36 equal monthly installments on the last day of each month following November 9, 2024. Read SEC document |
| November 02, 2023 Filed Nov 3, 2023 19:59 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 90 | $1.61 | $144.90 |
DisclosureSEC source: 0001709738-23-000012 · primary_doc.xml · nonDerivative · entry 1 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 350,684 Read SEC document |
| October 31, 2023 Filed Nov 2, 2023 20:06 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 90 | $0.90 | $81.00 |
DisclosureSEC source: 0001709738-23-000011 · primary_doc.xml · nonDerivative · entry 1 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 350,774 Read SEC document |
| September 30, 2023 Filed Oct 3, 2023 19:31 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 90 | $0.89 | $80.14 |
DisclosureSEC source: 0001709738-23-000010 · primary_doc.xml · nonDerivative · entry 1 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 350,864 Read SEC document |
| August 31, 2023 Filed Sep 5, 2023 15:34 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 90 | $0.85 | $76.55 |
DisclosureSEC source: 0001709738-23-000009 · primary_doc.xml · nonDerivative · entry 1 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 350,954 Read SEC document |
| July 31, 2023 Filed Aug 1, 2023 19:51 UTC | NEUROONE MEDICAL TECHNOLOGIES Corp NMTC · Entity 7808 | Tax withholdingCommon Stock | 90 | $1.02 | $91.80 |
DisclosureSEC source: 0001709738-23-000008 · primary_doc.xml · nonDerivative · entry 1 Christianson Mark · CIK 0001709738 · Business Development Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 351,044 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.